1
Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study
Condition(s): Submassive Pulmonary Embolism Last Updated: June 16, 2009Completed
19 Clinical Trials for: “Drotrecogin Alfa Activated”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
Safety and Dose Finding Study of Xigris in Hemodialysis Patients
Condition(s): End Stage Renal Disease Last Updated: July 20, 2012Completed
3
Disease Modification in Toxaemia of Pregnancy
Condition(s): Pre-eclampsia Last Updated: February 3, 2011Completed
4
Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS)
Condition(s): Pneumonia; Lipopolysaccharides Last Updated: March 15, 2011Completed
5
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
Condition(s): Sepsis Last Updated: August 20, 2012Completed
6
The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death
Condition(s): Sepsis Last Updated: December 5, 2007Completed
7
Activated Protein C and Corticosteroids for Human Septic Shock
Condition(s): Septic Shock Last Updated: May 21, 2012Suspended
8
Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion
Condition(s): Sepsis; Hypotension Last Updated: October 10, 2007Completed
9
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
Condition(s): Sepsis; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Infection Last Updated: December 3, 2007Completed
10
Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis
Condition(s): Sepsis Last Updated: November 15, 2007Completed
11
Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)
Condition(s): Severe Sepsis Last Updated: November 18, 2010Completed
12
Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock
Condition(s): Sepsis; Septic Shock Last Updated: August 26, 2009Completed
13
A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)
Condition(s): Sepsis Last Updated: January 24, 2007Completed
14
Quantifying Airway Inflammation With Radiologic Tests
Condition(s): Inflammation Last Updated: August 22, 2008Enrolling by invitation
15
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
Condition(s): Severe Sepsis; Septic Shock Last Updated: December 5, 2011Active, not recruiting
16
The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis
Condition(s): Sepsis Last Updated: July 18, 2006Completed
17
An Open Label Study of Severe Sepsis in Adults
Condition(s): Severe Sepsis Last Updated: December 5, 2007Completed
18
Follow-up Data of Patients Treated With XIGRIS® in France
Condition(s): Sepsis Last Updated: February 1, 2010Completed
19
Activated Protein C to Treat Acute Lung Injuries
Condition(s): Respiratory Distress Syndrome, Adult Last Updated: December 17, 2007Terminated
